Matches in Wikidata for { <http://www.wikidata.org/entity/Q46809317> ?p ?o ?g. }
- Q46809317 description "2005 nî lūn-bûn" @default.
- Q46809317 description "2005年の論文" @default.
- Q46809317 description "2005年学术文章" @default.
- Q46809317 description "2005年学术文章" @default.
- Q46809317 description "2005年学术文章" @default.
- Q46809317 description "2005年学术文章" @default.
- Q46809317 description "2005年学术文章" @default.
- Q46809317 description "2005年學術文章" @default.
- Q46809317 description "2005年學術文章" @default.
- Q46809317 description "2005年學術文章" @default.
- Q46809317 description "2005年學術文章" @default.
- Q46809317 description "2005年學術文章" @default.
- Q46809317 description "2005年學術文章" @default.
- Q46809317 description "2005년 논문" @default.
- Q46809317 description "article científic" @default.
- Q46809317 description "article scientific" @default.
- Q46809317 description "article scientifique (publié 2005)" @default.
- Q46809317 description "articol științific" @default.
- Q46809317 description "articolo scientifico" @default.
- Q46809317 description "artigo científico (publicado na 2005)" @default.
- Q46809317 description "artigo científico (publicado na 2005)" @default.
- Q46809317 description "artigo científico" @default.
- Q46809317 description "artikull shkencor" @default.
- Q46809317 description "artikulong pang-agham" @default.
- Q46809317 description "artykuł naukowy" @default.
- Q46809317 description "artículo científico publicado en 2005" @default.
- Q46809317 description "artículu científicu" @default.
- Q46809317 description "bilimsel makale" @default.
- Q46809317 description "bài báo khoa học" @default.
- Q46809317 description "mokslinis straipsnis" @default.
- Q46809317 description "naučni članak" @default.
- Q46809317 description "scienca artikolo" @default.
- Q46809317 description "scientific article" @default.
- Q46809317 description "teaduslik artikkel" @default.
- Q46809317 description "tieteellinen artikkeli" @default.
- Q46809317 description "tudományos cikk" @default.
- Q46809317 description "vedecký článok" @default.
- Q46809317 description "vetenskaplig artikel" @default.
- Q46809317 description "videnskabelig artikel (udgivet 2005)" @default.
- Q46809317 description "vitenskapelig artikkel" @default.
- Q46809317 description "vitskapeleg artikkel" @default.
- Q46809317 description "vědecký článek" @default.
- Q46809317 description "wetenschappelijk artikel" @default.
- Q46809317 description "wissenschaftlicher Artikel" @default.
- Q46809317 description "επιστημονικό άρθρο" @default.
- Q46809317 description "мақолаи илмӣ" @default.
- Q46809317 description "мақолаи илмӣ" @default.
- Q46809317 description "наукова стаття, опублікована в листопаді 2005" @default.
- Q46809317 description "научна статия" @default.
- Q46809317 description "научная статья" @default.
- Q46809317 description "научни чланак" @default.
- Q46809317 description "научни чланак" @default.
- Q46809317 description "գիտական հոդված" @default.
- Q46809317 description "מאמר מדעי" @default.
- Q46809317 description "سائنسی مضمون" @default.
- Q46809317 description "مقالة علمية" @default.
- Q46809317 description "مقالهٔ علمی" @default.
- Q46809317 description "২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46809317 description "บทความทางวิทยาศาสตร์" @default.
- Q46809317 description "სამეცნიერო სტატია" @default.
- Q46809317 name "Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I" @default.
- Q46809317 name "Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I" @default.
- Q46809317 type Item @default.
- Q46809317 label "Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I" @default.
- Q46809317 label "Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I" @default.
- Q46809317 prefLabel "Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I" @default.
- Q46809317 prefLabel "Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I" @default.
- Q46809317 P1433 Q46809317-B5B4F78A-7225-4F11-A848-2B33153858A1 @default.
- Q46809317 P1476 Q46809317-4325991E-6C0C-4334-9C16-CB9882232E30 @default.
- Q46809317 P2093 Q46809317-21A8669B-9516-4C06-BDB7-4E986D39B9CF @default.
- Q46809317 P2093 Q46809317-4442C1A7-0792-44F4-B4C3-2BF06B88FCD4 @default.
- Q46809317 P2093 Q46809317-4F9AF350-BE17-4238-8836-57975E810068 @default.
- Q46809317 P2093 Q46809317-7726B868-7AF6-49E5-91AA-623D9A7650A4 @default.
- Q46809317 P2093 Q46809317-AF14AD42-27AB-4DDF-BAFB-4E744A4489CA @default.
- Q46809317 P2093 Q46809317-B6A677E8-AC34-4894-B21F-E25BA3C9C633 @default.
- Q46809317 P2093 Q46809317-C4EDF9AA-7CDB-4C28-908F-FEB0DDDDF171 @default.
- Q46809317 P2093 Q46809317-DC5FDE1A-145C-4BE5-B61B-494D88B1EC47 @default.
- Q46809317 P2093 Q46809317-F6D42FD6-710E-400A-9948-2229A3E55442 @default.
- Q46809317 P2093 Q46809317-F976E0EB-535B-4AE9-B285-E51FCD73550C @default.
- Q46809317 P304 Q46809317-503C34CA-0EB5-4E02-A8FE-6E80D34ABE1C @default.
- Q46809317 P31 Q46809317-70F2ED6B-1F1A-43CF-BB1F-F3ACF849B64A @default.
- Q46809317 P356 Q46809317-6AD0034A-CED2-448E-82F2-55BE64E23AAD @default.
- Q46809317 P407 Q46809317-C8320B98-6987-4C85-9F9C-C97DCDDDC0AE @default.
- Q46809317 P433 Q46809317-82A6DD73-1BB7-49B4-8B8B-606136789CAC @default.
- Q46809317 P478 Q46809317-BBEF13AD-2EE2-4AAB-82E9-33043D536137 @default.
- Q46809317 P577 Q46809317-6907A2D4-0C66-4824-B7B4-453F45D51476 @default.
- Q46809317 P698 Q46809317-7C89E575-FA1A-479A-9C3B-2F8B324DB48C @default.
- Q46809317 P8608 Q46809317-3655F3D9-308A-488A-B9E4-D37A7FE0646F @default.
- Q46809317 P921 Q46809317-560097BC-77D7-4609-B848-CAAE50858937 @default.
- Q46809317 P921 Q46809317-B6C0C247-2ACA-4261-BC20-951523127FC1 @default.
- Q46809317 P921 Q46809317-D3846AB8-7ED1-4EAE-B3B3-2D567C831AAD @default.
- Q46809317 P921 Q46809317-E7EFB9E2-4622-4663-ADFE-C8DE9F2FD3D2 @default.
- Q46809317 P356 JCO.2005.08.071 @default.
- Q46809317 P698 16293862 @default.
- Q46809317 P1433 Q400292 @default.
- Q46809317 P1476 "Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I" @default.
- Q46809317 P2093 "Alan P Lyss" @default.
- Q46809317 P2093 "C Kent Osborne" @default.
- Q46809317 P2093 "Craig Allred" @default.
- Q46809317 P2093 "Danika Lew" @default.